Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the... see more

TSX:CPH - Post Discussion

Cipher Pharmaceuticals Inc > CPH Buys Back Another 205,000 shares in Q4 2020 !
View:
Post by stockfy on Feb 11, 2021 4:31am

CPH Buys Back Another 205,000 shares in Q4 2020 !

Profitable and debt-free CPH knows that it's dirt cheap because it currently trades less than 2 times its 2020 EBITDA. As such, it just announced that it bought back 205,000 shares in Q4 2020, facts below:


"Update on normal course issuer bid ("NCIB") program: During the quarter ended December 31, 2020 Cipher purchased for cancellation 205,500 common shares under the NCIB program."


https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc


Reminder. CPH bought back another 30,000 shares in Q3 2020 at C$1.14, facts below:
 
"During the period ended September 30, 2020, the Company purchased for cancellation 30,000 common shares at an average price of CAD$1.14 per common share."

Comment by Northforce13 on Feb 25, 2021 10:28am
Well, that's a positive point in the company's favor.   What's odd is I don't see any purchases by the company listed on insider trading, nor on sedi upon deeper investigation, am I missing something for real heh?
Comment by stockfy on Mar 03, 2021 5:22pm
Facts from CPH's report.
Comment by pabaloo on Mar 03, 2021 5:27pm
Yup they bought the rest of mine for .98 cents. When they stop buying it's going to .50 cents. Also Maxie I see you bought in 2017 for around 5 bucks! Pretty smart decision. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities